The BRCA-P Study was presented at the American Society of Clinical Oncology’s (ASCO) 2022 Annual Meeting! Read more…
RANK ligand: A potential target for breast cancer prevention in BRCA1 mutation carriers. Read more…
The BRCA-P Study is now enrolling—Join us!
Dana-Farber has a new BRCA Center! Learn more…
BRCA-P Study launches in Australia. Read more…